Guo, Y. Wang Yong-qing. Confusion in diagnosis and treatment of cervical insufficiency[J]. Int. Reprod. Health/Fam Plan. 37 (05), 417–421 (2018).
DaCosta, V. et al. Laparoscopic cervicoisthmic cerclage for the treatment of cervical incompetence: case reports. West. Indian Med. J. 60 (5), 590–593 (2011).
Brown, R., Gagnon, R. & Delisle, M. F. 373-Cervical insufficiency and cervical cerclage. J. Obstet. Gynaecol. Can. 41 (2), 233–247 (2019).
Goldenberg, R. L., Culhane, J. F., Iams, J. D. & Romero, R. Epidemiology and causes of preterm birth. Lancet 371 (9606), 75–84 (2008).
Roman, A., Suhag, A. & Berghella, V. Overview of cervical insufficiency: diagnosis, etiologies, and risk factors. Clin. Obstet. Gynecol. 59, 23–40 (2016).
Han, Y., Li, M., Ma, H. & Yang, H. Cervical insufficiency: a noteworthy disease with controversies. J. Perinat. Med. 48 (7), 648–655 (2020).
Gascón, A. et al. Cervical cerclage vs cervical Pessary in women with cervical insufficiency: A multicentric, open-label, randomised, controlled pilot trial [the CEPEIC trial]. Eur. J. Obstet. Gynecol. Reprod. Biol. X. 24, 100347 (2024).
Zhu, L. Q. et al. Effects of emergency cervical cerclage on pregnancy outcome: a retrospective study of 158 cases. Med. Sci. Monit. 21, 1395–1401 (2015).
Chen, Q., Chen, G. & Li, N. Clinical effect of emergency cervical cerclage and elective cervical cerclage on pregnancy outcome in the cervical-incompetent pregnant women. Arch. Gynecol. Obstet. 297 (2), 401–407 (2018).
Wang, Y., Gu, X., Tao, L. & Zhao, Y. Co-morbidity of cervical incompetence with polycystic ovarian syndrome (PCOS) negatively impacts prognosis: A retrospective analysis of 178 patients. BMC Pregnancy Childbirth. 16 (1), 308 (2016).
Feigenbaum, S. L. et al. Prevalence of cervical insufficiency in polycystic ovarian syndrome. Hum. Reprod. 27 (9), 2837–2842 (2012).
Meng, L., Öberg, S., Sandström, A., Wang, C. & Reilly, M. Identification of risk factors for incident cervical insufficiency in nulliparous and Parous women: a population-based case-control study. BMC Med. 20 (1), 348 (2022).
Anum, E. A., Hill, L. D., Pandya, A. & Strauss, J. F. 3rd Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta 30 (3), 207–215 (2009).
Spiegel, E., Nicholls-Dempsey, L., Czuzoj-Shulman, N. & Abenhaim, H. A. Pregnancy outcomes in women with Ehlers-Danlos syndrome. J. Matern Fetal Neonatal Med. 35 (9), 1683–1689 (2022).
Richard, D. et al. Calculating the sample size required for developing a clinical prediction model. BMJ 368, m441 (2020).
Meng, L., Öberg, S., Sandström, A. & Reilly, M. Association between infertility and cervical insufficiency in nulliparous women- the contribution of fertility treatment. Am. J. Obstet. Gynecol. 28, S0002-9378(24)01107-4.
Wu, Y. et al. Development and validation of a model for individualized prediction of cervical insufficiency risks in patients undergoing IVF/ICSI treatment. Reprod. Biol. Endocrinol. 19 (1), 6 (2021).
Sun, X. et al. Independent value of PMOI on hCG day in predicting pregnancy outcomes in IVF/ICSI cycles. Front. Endocrinol. (Lausanne). 14, 1086998 (2023).
Liu, B. et al. Association between maternal pre-pregnancy obesity and preterm birth according to maternal age and race or ethnicity: a population-based study. Lancet Diabetes Endocrinol. 7 (9), 707–714 (2019).
Shetelig Løvvik, T., Stridsklev, S., Carlsen, S. M., Salvesen, Ø. & Vanky, E. Cervical length and androgens in pregnant women with polycystic ovary syndrome: has Metformin any effect? J. Clin. Endocrinol. Metab. 101 (6), 2325–2331 (2016).
Makieva, S., Saunders, P. T. & Norman, J. E. Androgens in pregnancy: roles in parturition[J]. Hum. Reprod. Update. 20 (4), 542–559 (2014).
Sundtoft, I., Langhoff-Roos, J., Sandager, P., Sommer, S. & Uldbjerg, N. Cervical collagen is reduced in non-pregnant women with a history of cervical insufficiency and a short cervix. Acta Obstet. Gynecol. Scand. 96 (8), 984–990 (2017).
Timmons, B., Akins, M. & Mahendroo, M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol. Metab. 21 (6), 353–361 (2010).
Biffignandi, P., Massucchetti, C. & Molinatti, G. M. Female hirsutism: pathophysiological considerations and therapeutic implications. Endocr. Rev. 5 (4), 498–513 (1984).
Wu Jing, L. & Ruojia, C. Significance of different androgen indexes in the diagnosis of hyperandrogenemia in polycystic ovary syndrome. Zhejiang Med. J. 43 (5), 537–539 (2021).
Pankhurst, M. W. A putative role for anti-Mullerian hormone (AMH) in optimising ovarian reserve expenditure. J. Endocrinol. 233 (1), R1–R13 (2017).
Sun, X. et al. Comparison of the predictive capability of antral follicle count vs. the anti-Müllerian hormone for ovarian response in infertile women. Front. Endocrinol. (Lausanne). 13, 862733 (2022).
Sun, X. Y. et al. Relationship between Anti-Müllerian hormone and in vitro Fertilization-Embryo transfer in clinical pregnancy. Front. Endocrinol. (Lausanne). 11, 595448 (2020).
Hu, K. L., Liu, F. T., Xu, H., Li, R. & Qiao, J. High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome. Fertil. Steril. 113 (2), 444–452e1 (2020).
Hsu, J. Y. et al. Mullerian-Inhibiting Substance/Anti-Mullerian hormone as a predictor of preterm birth in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 103 (11), 4187–4196 (2018).
Kaing, A. et al. Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction. Fertil. Steril. 115 (2), 438–446 (2021).
Kang, J. Molecular Mechaisms of Mouse Mullerian Duct development[D] (Beijing, Beijing Xiehe Medical College Hospital, Chinese Academy of Medical Sciences,, 2020).
Song, J. Y. et al. Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer. Int. J. Oncol. 40 (6), 2013–2021 (2012).
Wei, Y. et al. Preconception diabetes mellitus and adverse pregnancy outcomes in over 6.4 million women: A population-based cohort study in China. PLoS Med. 16 (10), e1002926 (2019).
Michalik, L. & Wahli, W. Involvement of PPAR nuclear receptors in tissue injury and wound repair. J. Clin. Invest. 116 (3), 598–606 (2006).
Werner, S. & Grose, R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83 (3), 835–870 (2003).
Khamaisi, M. et al. PKCδ Inhibition normalizes the wound-healing capacity of diabetic human fibroblasts. J. Clin. Invest. 126 (3), 837–853 (2016).
Li, R. et al. Prevalence of polycystic ovary syndrome in women in china: A large Community-Based study. Hum. Reprod. 28 (9), 2562–2569 (2013).
Hawkins, L. K., Correia, K. F., Srouji, S. S., Hornstein, M. D. & Missmer, S. A. Uterine length and fertility outcomes: a cohort study in the IVF population. Hum. Reprod. 28 (11), 3000–3006 (2013).
Gökçe, A. et al. The association between operative hysteroscopy prior to assisted reproductive technology and cervical insufficiency in second trimester. Arch. Gynecol. Obstet. 303 (5), 1347–1352 (2021).
Shi, Y. et al. Transfer of fresh versus frozen embryos in ovulatory women. N Engl. J. Med. 378 (2), 126–136 (2018).
Liu, Y., Li, R. & Wang, Y. Clinical outcomes and placental pathological characteristics after fresh embryo transfer and frozen-thawed embryo transfer with different endometrial Preparation protocols. Placenta 131, 65–70 (2023).